£0
Zinc VC has led a pre-seed funding round in Native Labs to accelerate platform deployment and feature development.
Native Labs builds artificial intelligence technology to improve cell and gene therapy manufacturing.
Native Labs develops artificial intelligence platforms to address manufacturing bottlenecks in the production of cell and gene therapies. The company combines advanced technology with industry expertise to support biopharma development.
Louis Brookstein
CEO
Arya Shabani
Zinc VC has led a pre-seed funding round in Native Labs to accelerate platform deployment and feature development.